M1 macrophage-related prognostic model by combining bulk and single-cell transcriptomic data in NSCLC

Zhe Liu (Co-first Author), Fang Liu (Co-first Author), Olutomilayo Olayemi Petinrin, Muhammad Toseef, Nanjun Chen*, Zhongxu Zhu*, Ka-Chun Wong*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

5 Downloads (CityUHK Scholars)

Abstract

Aim: Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) is the most common subtype. Despite recent advancements in diagnostics and therapies, only a small percentage of patients benefit from immunotherapies. This underscores the urgent need to identify prognostic biomarkers for accurately assessing outcomes and providing treatment recommendations for NSCLC patients. Single-cell RNA sequencing (scRNA-seq) has revealed the heterogeneity of tumor-associated macrophages. Macrophages consist of M0, M1, and M2 subsets. M1 macrophages are often associated with improved clinical outcomes in various malignancies. However, there are no systematic studies on risk biomarkers for prognosticating NSCLC. Methods: CIBERSORT was used to calculate the macrophage subset infiltration percentage in bulk RNA-seq data from TCGA and GEO. The M1-related module was identified using the WGCNA algorithm. Potential M1 macrophage prognosis-associated genes were defined as the overlapping genes between marker genes in the M1 subpopulation from scRNA-seq data and prognosis-associated genes in M1 infiltrating cells. Results: Four risk genes (ADAM19, ICAM3, WIPF1, and LAP3) were identified through LASSO and multivariate Cox regression analysis. Forest plots demonstrated that the scoring model was an independent risk factor. A nomogram was provided to predict the prognosis of NSCLC patients. Finally, we validated the four risk genes at the protein expression levels and for copy number variations. Conclusions: In summary, our studies identified four risk genes related to M1 macrophages and presented a risk-scoring system to predict the outcomes of patients with NSCLC by integrating bulk and single-cell data. © The Author(s) 2024.
Original languageEnglish
Pages (from-to)750-773
JournalExploration of Medicine
Volume5
Issue number6
Online published6 Nov 2024
DOIs
Publication statusPublished - 2024

Funding

This research was substantially sponsored by the research projects [No. 32170654; No. 32000464] supported by the National Natural Science Foundation of China and was substantially supported by the Shenzhen Research Institute, City University of Hong Kong. This project is substantially funded by the Strategic Interdisciplinary Research Grant of City University of Hong Kong [No. 2021SIRG036]. The work described in this paper was substantially supported by the grant from the Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region [07181426]. The work described in this paper was partially supported by the grants from City University of Hong Kong [CityU 11203520, CityU 11203221]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Research Keywords

  • M1 macrophage
  • NSCLC
  • prognosis
  • scRNA-seq
  • TCGA
  • WGCNA

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'M1 macrophage-related prognostic model by combining bulk and single-cell transcriptomic data in NSCLC'. Together they form a unique fingerprint.

Cite this